« Previous
Next »
Women's Health Issues
Volume 20, Issue 1
, Pages
35-42
, January 2010
Impact of Patient Adherence and Test Performance on the Cost-Effectiveness of Cervical Cancer Screening in Developing Countries: The Case of Honduras
-
Cost-effectiveness analysis of VIA and Pap smears. The cost effectiveness of no screening, screening with Pap smears (three visits), and screening with VIA (two visits). Effectiveness is measured as t
Cost-effectiveness analysis of VIA and Pap smears. The cost effectiveness of no screening, screening with Pap smears (three visits), and screening with VIA (two visits). Effectiveness is measured as the percentage of cancer cases avoided in the 10 years after screening. Costs are represented in U.S. dollars. VIA demonstrated extended dominance over the Pap smear.
Funding for the cervical cancer prevention project from which primary data was gathered was provided by the Alliance for Cervical Cancer Prevention Small Grants Program. Funding for research was provided by the Building Interdisciplinary Careers in Women's Health (BIRCWH) Scholar Program K12-HD43444.
PII: S1049-3867(09)00102-9
doi: 10.1016/j.whi.2009.09.001
© 2010 Jacobs Institute of Women's Health. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Women's Health Issues
Volume 20, Issue 1
, Pages
35-42
, January 2010
